|
|
| 33.82 Data as of Apr 17 |  +0.40 / +1.20%Today’s Change | 19.74 Today|||52-Week Range 39.89 | +4.61% Year-to-Date |
| NuVasive Gets Unfavorable Trademark Verdict - Analyst Blog Apr 08 / Zacks.com |
| Previous close | 33.43 |
| Today’s open | 33.22 |
| Day’s range | 33.01 - 34.07 |
| Volume | 254,410 |
| Average volume (3 months) | 408,053 |
| Market cap | $1.6B |
| Dividend yield | -- |
| Earnings growth (last year) | +142.86% |
| Earnings growth (this year) | -11.89% |
| Earnings growth (next 5 years) | +11.58% |
| Revenue growth (last year) | +10.47% |
| P/E ratio | NM |
| Price/Sales | 2.10 |
| Price/Book | 2.55 |
| Today’s change | Today’s % change | |
|---|---|---|
| ARTCArthroCare Corp | +0.11 | +0.23% |
| MASIMasimo Corp | +0.25 | +0.95% |
| HAEHaemonetics Corp | +0.19 | +0.58% |
| IARTIntegra LifeSciences... | -0.22 | -0.48% |
| Next reporting date | April 30, 2014 |
| EPS forecast (this quarter) | $0.23 |
| Annual revenue (last year) | $685.2M |
| Annual profit (last year) | $7.9M |
| Net profit margin | 1.15% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Alexis V. Lukianov |
President & Chief Operating Officer Keith C. Valentine |
Corporate headquarters San Diego, California |
.
